"Observe Medical´s vision is to develop innovative medical technology products that benefit patients and healthcare professionals."

We are dedicated to releasing new products on a regular basis. After many years within larger medical technology corporations, working with a broad range of products. We realised the huge demand for new solutions from our customers. These larger corporations however lack the possibility to act fast on product development. Observe Medical is a small company whose owners have experience from many successful innovations over the years. Our mission is to establish this force within the life science field.

ISO 13485 certified

Investors

SEED Capital SEED Capital is Denmark’s biggest venture capital fund within the seed segment and specializes in identifying, financing and developing competent and innovative entrepreneurial companies developing the Life Science, Cleantech and IT companies of the future from seed stage to exit.seedcapital.dk
Investment Manager: Jón Ingi Benediktsson

Porter & Partners is a privately held investment firm focusing on early to mid stage companies.
Investment Director: Magnus Magnusson

M2 Capital Management AB is a private investment firm focusing on early to mid stage companies.
Investment Director: Rutger Arnhult

Lavin AB is also a privately held investment firm focusing on companies within life science. The primary investment focus is companies near to market with innovative products or solutions.
Investment Director: Magnus Emmoth

Management

Magnus Emmoth
B.Sc. MBA-CEO

During the past seven years Magnus has been working as CEO and board member in several healthcare companies. He has actively developed and grown business concepts from early stage to fully operational companies. Additionally, Magnus has raised over 200 MSEK in equity capital for three companies. Magnus holds a B.Sc. from Uppsala University and an MBA from Kellogg School of Management, Chicago.



Mikael Charléz
M.Sc. MBA-COO

Mikael has for the past 16 years been working with Sales & Marketing and Business Development in companies from early stage to market leading global firms. IP strategy is one of Mikael´s specialty areas. His work in this area has during the past six years generated several granted patents. Mikael holds an M.Sc. From the University of Gothenburg and an MBA from Gothenburg Business School (Handelshögskolan).



Mikael Löfgren
M.Sc.E.E. -CTO

Mikael has extensive experience from R&D within sensor applications. Mikael was with his team responsible for the commercialisation of the world first digital single use chest drainage unit. He was lead responsible for the difficult task of integrating two MEMS sensors in a mechanical plastic system for single use. Prior to that he was an engineer at the micromechanical sensor division of Imego, Institute of Microelectronics in Gothenburg. Mikael holds an M.Sc. in Electrical Engineering from Lund Institute of Technology.

Board

Jón Ingi Benediktsson
M.Sc., Chairman

Jón Ingi has been chairman of the board since early 2010. He has more than twenty years of experience in life science working in areas such as sales and marketing, general management, financing and strategy. He has a well established network within the healthcare sector and is a specialist in medical technologies. Jon Ingi holds a B.Sc. degree in Biology from the University of Iceland and Cand Scient (M.Sc) degree in Human Physiology from the University of Copenhagen.


Claes Wenthzel
B.Sc.

Claes has extensive experience running listed companies within the life science field. He has been actively involved in several listings and exits from the stock exchange. Present CFO at Kemetyl Group, the biggest supplier of industrial ethanol in Europe with filling platforms across Europe, Former Deputy CEO & CFO for the listed companies Orexo AB (publ.) 2005 – 2010 and Perbio Science AB (publ.) 1999 – 2004, and Board of Director & Chairman in Stille AB (publ.) 2006 – 2011


Kurt Erling Birk
B.Sc.

Kurt Erling Birk has been a member of the Board since 2011. Kurt brings valuable experience from within the medical technology field, particularly urine measurement since he owned one of the worlds largest producers of urine measurement equipment: UnoPlast A/S. During the period 1999 to 2008 he was employed as President & CEO in the Danish listed medical device company Ambu A/S where he very successfully turned the company around. He started his medical device career with UnoPlast A/S in 1977, where he advanced to be the owner, President & CEO. He holds a number of board appointments in industrial companies and has been the Chairman of the Danish Medical Device Association.


Ulla Brockenhuus-Schack
MBA, Columbia Business School

Ulla has been a Managing Partner of SEED Capital – the most active venture firm in Denmark since 2003. Prior to that she gained more than twenty years of experience working with innovation and business development within established companies like Egmont and McKinsey and she helped establish startups like game developer IO interactive and the virtual factory outlet Harburi. She also has an extensive network within venture, media and the political sphere. She is currently a board member of Amminex, Alkalon, DVCA, Tivoli and Mary Fonden. Ulla holds an MBA from Columbia Business School.